Evidence map›Paper›PMID 25919012›Full record

Trial reportPLoS medicine2015

HIV shedding from male circumcision wounds in HIV-infected men: a prospective cohort study.

Aaron A R Tobian, Godfrey Kigozi, Jordyn Manucci, Mary K Grabowski, David Serwadda, Richard Musoke, Andrew D Redd, Fred Nalugoda, Steven J Reynolds, Nehemiah Kighoma and 6 more

Open access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in PLoS medicine, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.4field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 9 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Penile Immune Activation and Risk of HIV Shedding: A Prospective Cohort Study.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2017
    Article
  5. Article
  6. Article
  7. Review
  8. Observational
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 4 institutions in 2 countries.

Aaron A R TobianDepartment of Pathology, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Rakai Health Sciences Program, Entebbe, Uganda.
Godfrey KigoziRakai Health Sciences Program, Entebbe, Uganda.
Jordyn ManucciDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America.
Mary K GrabowskiDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
David SerwaddaRakai Health Sciences Program, Entebbe, Uganda; Institute of Public Health, Makerere University, Kampala, Uganda.
Richard MusokeRakai Health Sciences Program, Entebbe, Uganda.
Andrew D ReddDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Fred NalugodaRakai Health Sciences Program, Entebbe, Uganda.
Steven J ReynoldsRakai Health Sciences Program, Entebbe, Uganda; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Nehemiah KighomaRakai Health Sciences Program, Entebbe, Uganda.
Oliver LaeyendeckerDepartment of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Justin LesslerDepartment of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Ronald H GrayRakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Thomas C QuinnRakai Health Sciences Program, Entebbe, Uganda; Department of Medicine, School of Medicine, Johns Hopkins University, Baltimore, Maryland, United States of America; Division of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland, United States of America.
Maria J WawerRakai Health Sciences Program, Entebbe, Uganda; Department of Epidemiology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, Maryland, United States of America.
Rakai Health Sciences Program
Rakai Health Sciences Program · UGJohns Hopkins University · USMakerere University · UGNational Institutes of Health · US

Funding

International Center for Excellence in Research (ICER) in Uganda: Impact of ARVsZIAAI001040 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REYNOLDS, STEVEN · 2009 to 2025
$23.5M
International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
Male Circumcision and Use of Foreskin Tissues for HIV Prevention in UgandaD43TW009578 · FIC · JOHNS HOPKINS UNIVERSITY · PI GRAY, RONALD H · 2013 to 2017
$1.3M
Oncogenic HPV, Mucosal Immune Response and Risk of HIV AcquisitionK23AI093152 · NIAID · JOHNS HOPKINS UNIVERSITY · PI TOBIAN, AARON A · 2011 to 2015
$684k
FIC NIH HHS 1D43TW009578-01FIC NIH HHS D43 TW009578Intramural NIH HHSNIAID NIH HHS 1K23AI093152-01A1NIAID NIH HHS K23 AI093152NIAID NIH HHS T32AI102
6 · The paper itself

Abstract

backgroundA randomized trial of voluntary medical male circumcision (MC) of HIV-infected men reported increased HIV transmission to female partners among men who resumed sexual intercourse prior to wound healing. We conducted a prospective observational study to assess penile HIV shedding after MC. METHODS AND

findingsHIV shedding was evaluated among 223 HIV-infected men (183 self-reported not receiving antiretroviral therapy [ART], 11 self-reported receiving ART and had a detectable plasma viral load [VL], and 29 self-reported receiving ART and had an undetectable plasma VL [<400 copies/ml]) in Rakai, Uganda, between June 2009 and April 2012. Preoperative and weekly penile lavages collected for 6 wk and then at 12 wk were tested for HIV shedding and VL using a real-time quantitative PCR assay. Unadjusted prevalence risk ratios (PRRs) and adjusted PRRs (adjPRRs) of HIV shedding were estimated using modified Poisson regression with robust variance. HIV shedding was detected in 9.3% (17/183) of men not on ART prior to surgery and 39.3% (72/183) of these men during the entire study. Relative to baseline, the proportion shedding was significantly increased after MC at 1 wk (PRR = 1.87, 95% CI = 1.12-3.14, p = 0.012), 2 wk (PRR = 3.16, 95% CI = 1.94-5.13, p < 0.001), and 3 wk (PRR = 1.98, 95% CI = 1.19-3.28, p = 0.008) after MC. However, compared to baseline, HIV shedding was decreased by 6 wk after MC (PRR = 0.27, 95% CI = 0.09-0.83, p = 0.023) and remained suppressed at 12 wk after MC (PRR = 0.19, 95% CI = 0.06-0.64, p = 0.008). Detectable HIV shedding from MC wounds occurred in more study visits among men with an HIV plasma VL > 50,000 copies/ml than among those with an HIV plasma VL < 400 copies/ml (adjPRR = 10.3, 95% CI = 4.25-24.90, p < 0.001). Detectable HIV shedding was less common in visits from men with healed MC wounds compared to visits from men without healed wounds (adjPRR = 0.12, 95% CI = 0.07-0.23, p < 0.001) and in visits from men on ART with undetectable plasma VL compared to men not on ART (PRR = 0.15, 95% CI = 0.05-0.43, p = 0.001). Among men with detectable penile HIV shedding, the median log10 HIV copies/milliliter of lavage fluid was significantly lower in men with ART-induced undetectable plasma VL (1.93, interquartile range [IQR] = 1.83-2.14) than in men not on ART (2.63, IQR = 2.28-3.22, p < 0.001). Limitations of this observational study include significant differences in baseline covariates, lack of confirmed receipt of ART for individuals who reported ART use, and lack of information on potential ART initiation during follow-up for those who were not on ART at enrollment.

conclusionPenile HIV shedding is significantly reduced after healing of MC wounds. Lower plasma VL is associated with decreased frequency and quantity of HIV shedding from MC wounds. Starting ART prior to MC should be considered to reduce male-to-female HIV transmission risk. Research is needed to assess the time on ART required to decrease shedding, and the acceptability and feasibility of initiating ART at the time of MC.

Indexed as

Circumcision, MaleHIV-1PenisViral LoadAdultAntiviral AgentsFemaleHIV InfectionsHumansMalePrevalenceProspective StudiesSelf ReportUgandaWound InfectionWounds and InjuriesAntiviral Agents

Identifiers

PMID25919012
PMCPMC4412625
OpenAlexW2138080012

What OpenQuestion holds

Textmetadata
LicenceCC0
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.